drugset / Trial / NCT00859469
Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma
NaSingle-groupOpen-labelTreatment
Summary
In patients with pleural or peritoneal mesothelioma, what is the response rate to combined Oxaliplatin (ELOXATIN®) and Gemcitabine chemotherapy?
Timeline
- Start
- 2004-04
- Primary completion
- 2009-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | Intravenous |
| Subject | Oxaliplatin | Small molecule | 100 mg/m2 | Intravenous |